Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/437360
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2023-01-05T11:59:41Z-
dc.date.available2023-01-05T11:59:41Z-
dc.identifier.urihttp://hdl.handle.net/10603/437360-
dc.description.abstractEprosartan mesylate (EM) is an angiotensin receptor blocker that suffers from newlineextremely poor bioavailability owing to its poor solubility and poor permeability. The newlinework was directed at developing formulation strategies to enhance the aqueous newlinesolubility and thereby its oral bioavailability. This would enable a reduction in the dose newlinewhich would eventually lead to fewer side effects. This work was divided into two newlinestudies, the first involved the formulation of EM nanosuspension, and the second study newlineinvolved the preparation of an EM-loaded self-nanoemulsifying drug delivery system newline(SNEDDS). newlineOptimization and characterization of nanosuspension based delivery of newlineeprosartan mesylate newlineThe rationale of the present work was to design the drug delivery system capable of newlineovercoming the solubility and bioavailability constraints of EM by preparing a newlinenanoemulsion. Quality by design principles was implemented to understand the product newlineand process variables of the sonoprecipitation technique, for the preparation of EM newlinenanosuspension. A quality risk management approach was utilized to identify and newlineassess high-risk attributes affecting critical quality attributes (CQA s), prioritizing the newlinenumber of experiments. The effect of the critical material attribute (CMA s) and critical newlineprocess parameter (CPP s) (ultrasonication amplitude, Soluplus® concentration, and newlinedrug concentration) on z-average particle size and PDI were investigated using central newlinecomposite face-centered design (CCF). Further, a design space with criteria set of newlineCMA s and CPP s was established to assure quality. The optimal formulation, newlineidentified using the numerical optimization method, was further lyophilized and newlineevaluated for redispersibility, saturation solubility, and in vitro dissolution behavior. newlineThe EM nanoparticles were amorphous as confirmed by differential scanning newlinecalorimetry (DSC) and X-ray diffraction (XRD) studies.
dc.format.extentAll Pages
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titlean evaluation and design of knowledge discovery techniques for talent forecasting in human resource applicationInvestigation On Strategies to Improve Oral Bioavailability of Selected Bcs Class Iv Molecule
dc.title.alternative
dc.creator.researcherShekhawat, Prachi
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordPharmaceutics
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.description.note
dc.contributor.guidePokharkar, Varsha
dc.publisher.placePune
dc.publisher.universityBharati Vidyapeeth Deemed University
dc.publisher.institutionFaculty of Pharmaceutical Sciences
dc.date.registered2015
dc.date.completed2022
dc.date.awarded2022
dc.format.dimensions
dc.format.accompanyingmaterialNone
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Faculty of Pharmaceutical Sciences

Files in This Item:
File Description SizeFormat 
01_title page.pdfAttached File95.74 kBAdobe PDFView/Open
02_prelim pages.pdf489.08 kBAdobe PDFView/Open
03_contents.pdf156.57 kBAdobe PDFView/Open
04_abstract.pdf92.69 kBAdobe PDFView/Open
05_chapter1.pdf744.91 kBAdobe PDFView/Open
06_chapter2.pdf183.36 kBAdobe PDFView/Open
07_chapter3.pdf164.87 kBAdobe PDFView/Open
08_chapter4.pdf2.38 MBAdobe PDFView/Open
09_chapter5.pdf2.55 MBAdobe PDFView/Open
10_annexure.pdf221.09 kBAdobe PDFView/Open
80_recommendation.pdf194.18 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: